*This activity does not award CME*

*This activity is free of charge to those registered for ANA2021. Please click continue to access the content. Please contact us if you are prompted to pay the fee and were registered for the meeting.*

Description: Although stroke remains the fifth leading cause of death and the number one cause of serious long-term disability in the US, effective acute treatments (thrombolysis and thrombectomy) that reduce death and disability are available and indications keep expanding and evolving. Through case-based presentations and overview of current evidence, faculty will provide emerging applications of interventional treatments. This session with cover important topics, in particular: 1) preclinical and translational thrombolytic therapies; 2) advances in neuroimaging to define the ischemic core and penumbra; and 3) the continuously evolving role of flow diverting stents.

Chair: Diogo C. Haussen, MD, Emory University

Co-Chair: Alexandra Czap, MD, McGovern Medical School, University of Texas Health Science Center at Houston

Objective(s):

• Understand the future of thrombolytic therapies and the barriers to stroke treatment
• Review advances in neuroimaging to improve accuracy of patient triage and treatment
• Learn why large necked aneurysms were difficult to treat and how flow diverting stents revolutionized this landscape

Presentations:

Novel Preclinical Therapies for Thrombolysis

Speaker:

Shahid Nimjee, MD, PhD

The Ohio State University, Medical Center

Determination of the Ischemic Core

Speaker:

Seena Dehkharghani, MD

New York University, Langone Health

Flow Diverting Stents: Aneurysms and Beyond

Speaker: 

Maxim Mokin, MD, PhD

University of South Florida

Safety and Efficacy of Endovascular Therapy Referred by Telephone-based vs In-person Consultations

Oral Presenter: 

Sarah Nelson, MD, PhD

Mount Sinai Health System

*This session is not available for AMA PRA Category I Credit(s)™